The findings of our study, combined with those previously mentioned in other research, support the important role of systemic inflammatory markers, such as the PIV, the SII, and also the role of TLR4 in the progression of MASLD. The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatotic liver disease.